• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / U.S. Equity

A Blueprint for Highflier Stability

Cautionary tales that the IPO window might be closing at last.
By JIM CRAMER Apr 14, 2014 | 11:49 AM EDT
Stocks quotes in this article: CSOD, WDAY, BIIB, BMRN, ALXN, PAHC, LQ, ALLY, TWTR, VJET

We are getting some of the signs of stability that I have been looking for among highfliers, and I think we have a blueprint for how it can continue.

The first positive sign? Initial public offerings. I like to quote from Investor's Business Daily in these matters, and the top headline in the paper today speaks loudly: "IPO Frenzy Freezes as Four New Issues Fail to Debut Friday." The deals that didn't occur include a couple of biotechs and a human-resources-management company, two of the most thoroughly saturated sectors of this market. Those deals would be the last thing this market needs. The human-resources-management space is so crowded now that it has crushed the best of the best, Cornerstone onDemand (CSOD) and Workday (WDAY), which have repeatedly failed to find footing. A cessation of deals in that area, after a series of post-IPO disasters, is a welcome event.

What can I say about the need to cancel the biotech deals? The biotech index is down 22%. The selling in Biogen Idec (BIIB), BioMarin (BMRN) and Alexion (ALXN) on top of the hideous action in Gilead (GILD) were grim reminders of how we are full up in biotech. The collapse of a farmland real estate investment trust deal, which had dropped 7% below its pricing, and the reduction in Phibro Animal Health's (PAHC) pricing to a level that allowed a pop were also welcome news.

Unfortunately, Zoe's Kitchen (ZOES), a fast-food casual-restaurant chain, exploded higher on its offering Friday and the 65% pop shows you this travesty of an IPO season can still hurt existing companies. Far more representative were the two giant busted deals, La Quinta (LQ), a $2 billion company that trades at a discount to its IPO price, and Ally Financial (ALLY), an $11 billion company that's a full dollar below its offering price. Those are truly cautionary tales that the IPO window, open widest since 2006, according to Renaissance Capital, might be closing at last.

The other positive sign? I have been saying that Twitter (TWTR) has become the poster child for the IPO pullback, where people who bought it that first day, after a magnificent run, have now round-tripped and lost money. This morning the big-gun owners of Twitter -- Benchmark, Jack Dorsey and Dick Costolo-- announced they don't intend to sell stock any time soon.

This is a very important development because unless we see more of this kind of "I am not selling" self-ban, we are going to continue to question the longevity of these companies that have come public in this era. In the year 2000, we had far more like Voxeljet (VJET), the 3-D printing company that sold 3 million shares last week at $15, down from $70, than we had anti-selling statements from insiders like those of Twitter.

So many people do not understand how insider selling and IPOs can kill the bull. That's because they didn't trade or invest during 2000. These two are so important because they were signs that the companies were jokes and the insiders knew it.

Like The Who, we can't and won't be fooled again. 

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, has no positions in the stocks mentioned.

TAGS: Investing | U.S. Equity | IPOs

More from U.S. Equity

Zero-Covid? NATO's China Challenge, Quarter-End Volume, Yields, Trading Chevron

Stephen Guilfoyle
Jun 28, 2022 7:23 AM EDT

There was a time when Covid vaccine news was headline material. Not now, though, and this news could matter.

Kass: Why Markets Could Make a Yankees-Like Comeback

Doug Kass
Jun 27, 2022 2:00 PM EDT

I remain uncharacteristically bullish. Here's why.

Why I Just Can't Be More Positive About Stocks Right Now

James "Rev Shark" DePorre
Jun 27, 2022 11:13 AM EDT

Remember that countertrend bounce in May?

Indexes Break Resistance as Market Prospects Improve

Guy Ortmann
Jun 27, 2022 10:42 AM EDT

Friday's robust gains on heavy volume were helpful from a technical view.

The Fed Blinked and So Did We

Peter Tchir
Jun 27, 2022 9:30 AM EDT

Here's what we need to get a bigger rally.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:56 AM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    Check out what's going on in the Stocks Under $10 ...
  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login